Saba Khorrami

Ospedale San Donato

Papers

1

Total Citations

55

H-Index

1

About

Saba Khorrami is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH), with a particular focus on large-volume prostate glands. Her major contributions include pioneering comparative effectiveness research between Holmium laser enucleation of the prostate (HoLEP) and minimally invasive simple prostatectomy. In her landmark 2021 prospective multicenter randomized study—cited over 55 times—Khorrami demonstrated that HoLEP offers comparable functional outcomes to laparoscopic and robot-assisted simple prostatectomy for prostates ≥120 mL, while significantly reducing operative time and hospital stay. This work has helped shift clinical practice toward less invasive approaches for complex, large-volume BPH cases. Beyond this pivotal trial, Khorrami’s research portfolio addresses surgical innovation, perioperative outcomes, and patient-reported quality-of-life metrics. Her findings have been instrumental in establishing evidence-based guidelines for managing challenging prostate conditions, earning her recognition as a key voice in modern urologic surgery. For students and researchers, Khorrami exemplifies how rigorous clinical trials can directly transform surgical decision-making and improve patient recovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Holmium laser enucleation of prostate versus minimally invasive simple prostatectomy for large volume (≥120 mL) prostate glands: a prospective multicenter randomized study
55 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Ospedale San Donato

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago